Newsroom
In the News

Genomics profiled in The Times

24 March 2025
|
2
min read
The Times logo

The Times profiled Genomics and its CEO, Professor Sir Peter Donnelly, highlighting the company’s work on polygenic risk scores for common diseases. The piece explores how their MHRA-approved technology could reshape preventive healthcare, and the potential for rollout across the NHS.

This feature was originally published in The Times.

Read the full article
on
The Times